OptumRx, Catamaran Complete Merger; Mark Thierer Comments

acquisitionOptum has closed the merger of its pharmacy care services business OptumRx with Catamaran Corp. as part of efforts to expand the delivery of personalized pharmacy care to at least 65 million patients.

Optum said Thursday it acquired all shares of Catamaran at $61.50 per share in a cash transaction.

The combined companies will operate as OptumRx and utilize data analytics and other tools to facilitate synchronized and collaborative care management,  Optum added.

“OptumRx’s longtime business relationship and shared technology with Catamaran greatly simplifies the integration now underway, ” said Mark Thierer, former chairman and CEO of Catamaran and current CEO of the integrated OptumRx.

GovCon Wire Logo

Receive the Daily News Briefing And Events Updates Straight to Your Inbox

Related Articles